Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Har

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Immunology and Allergy Clinics of North America|October 3, 2017
Penicillin and Beta-Lactam HypersensitivityDaniel Har, Roland Solensky
Allergy and Asthma Proceedings|December 25, 2018
Systemic reaction rates with omalizumab, subcutaneous immunotherapy, and combination therapy in children with allergic asthmaDaniel Har, Min Jung Lee
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 19, 2013
Coordinated regulation of adipose tissue macrophages by cellular and nutritional signalsDaniel Har, Michelle Carey, Meredith Hawkins
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 22, 2015
Outcomes of using omalizumab for more than 1 year in refractory chronic urticariaDaniel Har, Saurin Patel, David A Khan
Current Allergy and Asthma Reports|February 23, 2018
Current Status of Potential Therapies for IgE-Mediated Food AllergyChristopher P Parrish, Daniel Har, J Andrew Bird
The Journal of Allergy and Clinical Immunology. in Practice|September 11, 2017
Recurrence of Chronic Urticaria: Incidence and Associated FactorsJulie K Kim, Daniel Har, L Steven Brown, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Immunology and Allergy Clinics of North America|October 3, 2017
Penicillin and Beta-Lactam HypersensitivityDaniel Har, Roland Solensky
Allergy and Asthma Proceedings|December 25, 2018
Systemic reaction rates with omalizumab, subcutaneous immunotherapy, and combination therapy in children with allergic asthmaDaniel Har, Min Jung Lee
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 19, 2013
Coordinated regulation of adipose tissue macrophages by cellular and nutritional signalsDaniel Har, Michelle Carey, Meredith Hawkins
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 22, 2015
Outcomes of using omalizumab for more than 1 year in refractory chronic urticariaDaniel Har, Saurin Patel, David A Khan
Current Allergy and Asthma Reports|February 23, 2018
Current Status of Potential Therapies for IgE-Mediated Food AllergyChristopher P Parrish, Daniel Har, J Andrew Bird
The Journal of Allergy and Clinical Immunology. in Practice|September 11, 2017
Recurrence of Chronic Urticaria: Incidence and Associated FactorsJulie K Kim, Daniel Har, L Steven Brown, et al.
Pageof 1